Robert S. Rahimi

3.2k total citations · 1 hit paper
65 papers, 1.8k citations indexed

About

Robert S. Rahimi is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Robert S. Rahimi has authored 65 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Hepatology, 41 papers in Epidemiology and 30 papers in Surgery. Recurrent topics in Robert S. Rahimi's work include Liver Disease and Transplantation (46 papers), Liver Disease Diagnosis and Treatment (39 papers) and Organ Transplantation Techniques and Outcomes (25 papers). Robert S. Rahimi is often cited by papers focused on Liver Disease and Transplantation (46 papers), Liver Disease Diagnosis and Treatment (39 papers) and Organ Transplantation Techniques and Outcomes (25 papers). Robert S. Rahimi collaborates with scholars based in United States, Canada and France. Robert S. Rahimi's co-authors include Don C. Rockey, Andrés Duarte‐Rojo, Jennifer C. Lai, Amit G. Singal, Elizabeth C. Verna, Jennifer A. Cuthbert, Daniela P. Ladner, Matthew R. Kappus, Dorry L. Segev and Michael L. Volk and has published in prestigious journals such as Gastroenterology, Hepatology and The American Journal of Medicine.

In The Last Decade

Robert S. Rahimi

62 papers receiving 1.8k citations

Hit Papers

TVB-2640 (FASN Inhibitor) for the Treatment of Nonalcohol... 2021 2026 2022 2024 2021 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert S. Rahimi United States 22 1.3k 1.1k 695 474 214 65 1.8k
Marie Sinclair Australia 18 693 0.5× 596 0.5× 209 0.3× 696 1.5× 122 0.6× 69 1.3k
Christian Labenz Germany 22 796 0.6× 1.0k 1.0× 384 0.6× 192 0.4× 53 0.2× 108 1.5k
Eric S. Orman United States 24 1.1k 0.8× 895 0.8× 922 1.3× 95 0.2× 35 0.2× 94 2.2k
Kavish R. Patidar United States 20 1.1k 0.8× 979 0.9× 628 0.9× 98 0.2× 12 0.1× 83 1.6k
Leyla de Avila United States 16 864 0.7× 2.0k 1.9× 381 0.5× 329 0.7× 20 0.1× 36 2.5k
Jessica L. Mellinger United States 27 1.3k 1.0× 2.1k 1.9× 473 0.7× 98 0.2× 11 0.1× 84 2.8k
M. Mazen Jamal United States 20 494 0.4× 821 0.7× 595 0.9× 131 0.3× 15 0.1× 44 2.1k
Eric R. Yoo United States 16 680 0.5× 1.1k 1.0× 257 0.4× 167 0.4× 8 0.0× 41 1.4k
Ayse L. Mindikoglu United States 22 879 0.7× 708 0.6× 472 0.7× 191 0.4× 4 0.0× 58 1.5k
Nathalie C. Leite Brazil 26 322 0.3× 1.0k 1.0× 294 0.4× 195 0.4× 16 0.1× 67 2.0k

Countries citing papers authored by Robert S. Rahimi

Since Specialization
Citations

This map shows the geographic impact of Robert S. Rahimi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert S. Rahimi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert S. Rahimi more than expected).

Fields of papers citing papers by Robert S. Rahimi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert S. Rahimi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert S. Rahimi. The network helps show where Robert S. Rahimi may publish in the future.

Co-authorship network of co-authors of Robert S. Rahimi

This figure shows the co-authorship network connecting the top 25 collaborators of Robert S. Rahimi. A scholar is included among the top collaborators of Robert S. Rahimi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert S. Rahimi. Robert S. Rahimi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brown, Robert S., et al.. (2025). Screening and management of portal hypertension and varices in cirrhosis: Expert perspectives. Hepatology Communications. 9(4).
2.
Steinberg, Alexandra, et al.. (2025). Psychomotor Speed From Minimal Hepatic Encephalopathy Testing Is Associated With Physical Frailty in Patients With Advanced Chronic Liver Disease. The American Journal of Gastroenterology. 121(3). 689–696. 1 indexed citations
3.
Wang, Melinda, Amy M. Shui, Chiung‐Yu Huang, et al.. (2024). The Liver Frailty Index enhances mortality risk prediction above and beyond MELD 3.0 alone. Liver Transplantation. 30(12). 1326–1329. 3 indexed citations
4.
Wang, Melinda, Sy Han Chiou, Daniel Ganger, et al.. (2024). Liver transplantation provides survival benefit at all levels of frailty: From the Multicenter Functional Assessment in Liver Transplantation Study. Hepatology. 81(4). 1269–1275. 3 indexed citations
5.
Ruck, Jessica M., Amy M. Shui, Robert S. Rahimi, et al.. (2023). Association of body mass index with post‐liver transplant outcomes. Clinical Transplantation. 38(1). e15205–e15205. 4 indexed citations
6.
Moosavi, Seyed Ali, Erfan Taherifard, Nasrin Motazedian, et al.. (2023). Frailty as a predictor of poor outcomes among patients awaiting liver transplant: a systematic review and meta-analysis. PubMed Central. 2 indexed citations
7.
Wang, Melinda, Amy M. Shui, Jessica M. Ruck, et al.. (2023). The liver frailty index is a predictor of healthcare utilization after liver transplantation in older adults. Clinical Transplantation. 38(1). e15219–e15219. 5 indexed citations
8.
Sundaram, Vinay, Kirti Shetty, Christina C. Lindenmeyer, et al.. (2022). Risk Factors for Posttransplantation Mortality in Recipients With Grade 3 Acute‐on‐Chronic Liver Failure: Analysis of a North American Consortium. Liver Transplantation. 28(6). 1078–1089. 22 indexed citations
9.
Rahimi, Robert S., et al.. (2022). Hepatic Encephalopathy: Current and Emerging Treatment Modalities. Clinical Gastroenterology and Hepatology. 20(8). S9–S19. 25 indexed citations
10.
Bajaj, Jasmohan S., Tarek Hassanein, Nikolaos Pyrsopoulos, et al.. (2022). Dosing of Rifaximin Soluble Solid Dispersion Tablets in Adults With Cirrhosis: 2 Randomized, Placebo-controlled Trials. Clinical Gastroenterology and Hepatology. 21(3). 723–731.e9. 17 indexed citations
11.
Kappus, Matthew R., Brian J. Boyarsky, Daniel Ganger, et al.. (2021). The relationship between frailty and cirrhosis etiology: From the Functional Assessment in Liver Transplantation (FrAILT) Study. Liver International. 41(10). 2467–2473. 21 indexed citations
12.
Rahimi, Robert S., Kimberly Brown, Steven L. Flamm, & Robert S. Brown. (2021). Overt Hepatic Encephalopathy: Current Pharmacologic Treatments and Improving Clinical Outcomes. The American Journal of Medicine. 134(11). 1330–1338. 19 indexed citations
13.
Sundaram, Vinay, Nadim Mahmud, Giovanni Perricone, et al.. (2020). Longterm Outcomes of Patients Undergoing Liver Transplantation for Acute‐on‐Chronic Liver Failure. Liver Transplantation. 26(12). 1594–1602. 46 indexed citations
14.
Lai, Jennifer C., Jennifer L. Dodge, Matthew R. Kappus, et al.. (2020). Changes in frailty are associated with waitlist mortality in patients with cirrhosis. Journal of Hepatology. 73(3). 575–581. 105 indexed citations
15.
Ryu, Alexander J., Robert S. Rahimi, & Michael D. Leise. (2020). The Current Hepatic Encephalopathy Pipeline. Journal of Clinical and Experimental Hepatology. 10(4). 377–385. 4 indexed citations
16.
Lai, Jennifer C., Robert S. Rahimi, Elizabeth C. Verna, et al.. (2019). Frailty Associated With Waitlist Mortality Independent of Ascites and Hepatic Encephalopathy in a Multicenter Study. Gastroenterology. 156(6). 1675–1682. 166 indexed citations
17.
Sundaram, Vinay, Robert J. Wong, Constantine Karvellas, et al.. (2019). Effect of the clinical course of acute-on-chronic liver failure prior to liver transplantation on post-transplant survival. Journal of Hepatology. 72(3). 481–488. 94 indexed citations
18.
Rubin, Jessica B., Marie Sinclair, Robert S. Rahimi, Elliot B. Tapper, & Jennifer C. Lai. (2018). Women on the liver transplantation waitlist are at increased risk of hospitalization compared to men. World Journal of Gastroenterology. 25(8). 980–988. 16 indexed citations
19.
Flores, Avegail, et al.. (2016). Severe Cholestasis and Bile Acid Nephropathy From Anabolic Steroids Successfully Treated With Plasmapheresis. ACG Case Reports Journal. 3(1). 133–135. 21 indexed citations
20.
Rahimi, Robert S. & Jacqueline G. O’Leary. (2015). Post-Liver Transplant Hepatitis C Therapy. Current Treatment Options in Gastroenterology. 13(2). 249–258. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026